Novel drug discovery approaches for treating arenavirus infections

References

• Radoshitzky SR, Bao Y, Buchmeier MJ, et al. Past, present, and future of arenavirus taxonomy. Arch Virol. 2015 Jul;160(7):1851–1874. doi:10.1007/s00705-015-2418-y.
   PubMed Web of Science ®Google Scholar
• Sayler KA, Barbet AF, Chamberlain C, et al. Isolation of Tacaribe virus, a Caribbean arenavirus, from host-seeking Amblyomma americanum ticks in Florida. PLoS One. 2014;9(12):e115769. doi:10.1371/journal.pone.0115769.
   PubMed Web of Science ®Google Scholar
• Clegg JC. Molecular phylogeny of the arenaviruses. Curr Top Microbiol Immunol. 2002;262:1–24.
   PubMed Web of Science ®Google Scholar
• Manning JT, Forrester N, Paessler S. Lassa virus isolates from Mali and the Ivory Coast represent an emerging fifth lineage. Front Microbiol. 2015;6:1037. doi:10.3389/fmicb.2015.01037.
   PubMed Web of Science ®Google Scholar
• Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. BMJ. 2003 Nov 29;327(7426):1271–1275.
   PubMed Web of Science ®Google Scholar
• Freedman DO, Woodall J. Emerging infectious diseases and risk to the traveler. Med Clin North Am. 1999 Jul;83(4):865–883.
   PubMed Web of Science ®Google Scholar
• McCormick JB, Fisher-Hoch SP. Lassa fever. Curr Top Microbiol Immunol. 2002;262:75–109.
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat Med. 2004 Dec;10(12 Suppl):S110S121. doi:10.1038/nm1142.
   Google Scholar
• Grant A, Seregin A, Huang C, et al. Junin virus pathogenesis and virus replication. Viruses. 2012 Oct;4(10):2317–2339. doi:10.3390/v4102317.
   PubMed Web of Science ®Google Scholar
• Ambrosio A, Saavedra M, Mariani M, et al. Argentine hemorrhagic fever vaccines. Hum Vaccin. 2011 Jun;7(6):694–700.
   PubMed Web of Science ®Google Scholar
• Bonthius DJ, Nichols B, Harb H, et al. Lymphocytic choriomeningitis virus infection of the developing brain: critical role of host age. Ann Neurol. 2007 Oct;62(4):356–374. doi:10.1002/ana.21193.
   PubMed Web of Science ®Google Scholar
• Buchmeier MJ, Peters CJ, de la Torre JC. Arenaviridae: the viruses and their replication. In: Knipe DMHP, editor. Fields virology. 2007. Philadelphia: Lipincott Williams and Wilkins p. 1792–1827.
   Google Scholar
• Pinschewer DD, Perez M, de la Torre JC. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J Virol. 2003 Mar;77(6):3882–3887.
   PubMed Web of Science ®Google Scholar
• Perez M, Craven RC, de la Torre JC. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12978–12983. doi:10.1073/pnas.2133782100.
   PubMed Web of Science ®Google Scholar
• Strecker T, Eichler R, Meulen J, et al. Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol. 2003 Oct;77(19):10700–10705.
   PubMed Web of Science ®Google Scholar
• Qi X, Lan S, Wang W, et al. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature. 2010 Dec 9;468(7325):779–783. doi:10.1038/nature09605.
   PubMed Web of Science ®Google Scholar
• Kunz S, Edelmann KH, de la Torre JC, et al. Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. Virology. 2003 Sep 15;314(1):168–178.
   PubMed Web of Science ®Google Scholar
• Lenz O, Ter Meulen J, Klenk HD, et al. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12701–12705. doi:10.1073/pnas.221447598.
   PubMed Web of Science ®Google Scholar
• Beyer WR, Popplau D, Garten W, et al. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol. 2003 Mar;77(5):2866–2872.
   PubMed Web of Science ®Google Scholar
• Koma T, Huang C, Kolokoltsova OA, et al. Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses. J Mol Biol. 2013 Dec 13;425(24):4893–4903.
   PubMed Web of Science ®Google Scholar
• Borrow P, Martinez-Sobrido L, de la Torre JC. Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses. 2010 Nov;2(11):2443–2480. doi:10.3390/v2112443.
   PubMed Web of Science ®Google Scholar
• McCormick JB, King IJ, Webb PA, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987;155(3):445–455.
   PubMed Web of Science ®Google Scholar
• Moraz ML, Kunz S. Pathogenesis of arenavirus hemorrhagic fevers. Expert Rev Anti Infect Ther. 2011 Jan;9(1):49–59. doi:10.1586/eri.10.142.
   PubMed Web of Science ®Google Scholar
• Parker WB. Metabolism and antiviral activity of ribavirin. Virus Res. 2005 Feb;107(2):165–171. doi:10.1016/j.virusres.2004.11.006.
   PubMed Web of Science ®Google Scholar
• Borrow P, Oldstone MB. Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J Virol. 1992 Dec;66(12):7270–7281.
   PubMed Web of Science ®Google Scholar
• Eschli B, Quirin K, Wepf A, et al. Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins. J Virol. 2006 Jun;80(12):5897–5907. doi:10.1128/JVI.00008-06.
   PubMed Web of Science ®Google Scholar
• Podbilewicz B. Virus and cell fusion mechanisms. Annu Rev Cell Dev Biol. 2014;30:111–139. doi:10.1146/annurev-cellbio-101512-122422.
   PubMed Web of Science ®Google Scholar
• Nunberg JH, York J. The curious case of arenavirus entry, and its inhibition. Viruses. 2012 Jan;4(1):83–101. doi:10.3390/v4010083.
   PubMed Web of Science ®Google Scholar
• York J, Dai D, Amberg SM, et al. pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors. J Virol. 2008 Nov;82(21):10932–10939. doi:10.1128/JVI.01140-08.
   PubMed Web of Science ®Google Scholar
• Cao W, Henry MD, Borrow P, et al. Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus [see comments]. Science. 1998;282(5396):2079–2081.
   PubMed Web of Science ®Google Scholar
• Barresi R, Campbell KP. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci. 2006;119(Pt 2):199–207. doi:10.1242/jcs.02814.
   PubMed Web of Science ®Google Scholar
• Kanagawa M, Saito F, Kunz S, et al. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell. 2004 Jun 25;117(7):953–964.
   PubMed Web of Science ®Google Scholar
• Kunz S, Rojek JM, Kanagawa M, et al. Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol. 2005 Nov;79(22):14282–14296. doi:10.1128/JVI.79.22.14282-14296.2005.
   PubMed Web of Science ®Google Scholar
• Rojek JM, Spiropoulou CF, Campbell KP, et al. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan’s host-derived ligands. J Virol. 2007 Jun;81(11):5685–5695. doi:10.1128/JVI.02574-06.
   PubMed Web of Science ®Google Scholar
• Jae LT, Raaben M, Riemersma M, et al. Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry. Science. 2013 Apr 26;340(6131):479–483. doi:10.1126/science.1233675.
   PubMed Web of Science ®Google Scholar
• Shimojima M, Stroher U, Ebihara H, et al. Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. J Virol. 2012 Feb;86(4):2067–2078. doi:10.1128/JVI.06451-11.
   PubMed Web of Science ®Google Scholar
• Goncalves AR, Moraz ML, Pasquato A, et al. Role of DC-SIGN in Lassa virus entry into human dendritic cells. J Virol. 2013 Nov;87(21):11504–11515. doi:10.1128/JVI.01893-13.
   PubMed Web of Science ®Google Scholar
• Klaus JP, Eisenhauer P, Russo J, et al. The intracellular cargo receptor ERGIC-53 is required for the production of infectious arenavirus, coronavirus, and filovirus particles. Cell Host & Microbe. 2013 Nov 13;14(5):522–534.
   PubMed Web of Science ®Google Scholar
• Vela EM, Zhang L, Colpitts TM, et al. Arenavirus entry occurs through a cholesterol-dependent, non-caveolar, clathrin-mediated endocytic mechanism. Virology. 2007;13:13.
   Google Scholar
• Rojek JM, Sanchez AB, Nguyen NT, et al. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol. 2008 Aug;82(15):7677–7687. doi:10.1128/JVI.00560-08.
   PubMed Web of Science ®Google Scholar
• Quirin K, Eschli B, Scheu I, et al. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology. 2008 Aug 15;378(1):21–33.
   PubMed Web of Science ®Google Scholar
• Iwasaki M, Ngo N, de la Torre JC. Sodium hydrogen exchangers contribute to arenavirus cell entry. J Virol. 2014 Jan;88(1):643–654. doi:10.1128/JVI.02110-13.
   PubMed Web of Science ®Google Scholar
• Pasqual G, Rojek JM, Masin M, et al. Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog. 2011 Sep;7(9):e1002232. doi:10.1371/journal.ppat.1002232.
   Google Scholar
• Jae LT, Raaben M, Herbert AS, et al. Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science. 2014 Jun 27;344(6191):1506–1510. doi:10.1126/science.1252480.
   PubMed Web of Science ®Google Scholar
• Imperiali M, Thoma C, Pavoni E, et al. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function. J Virol. 2005 Nov;79(22):14297–14308. doi:10.1128/JVI.79.22.14297-14308.2005.
   PubMed Web of Science ®Google Scholar
• Weissenbacher MC, Laguens RP, Coto CE. Argentine hemorrhagic fever. Curr Top Microbiol Immunol. 1987;134:79–116.
   PubMedGoogle Scholar
• Peters CJ. Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol. 2002;262:65–74.
   PubMed Web of Science ®Google Scholar
• Abraham J, Kwong JA, Albarino CG, et al. Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog. 2009 Apr;5(4):e1000358. doi:10.1371/journal.ppat.1000706.
   PubMedGoogle Scholar
• Martinez MG, Cordo SM, Candurra NA. Characterization of Junin arenavirus cell entry. J Gen Virol. 2007 Jun;88(Pt 6):1776–1784. doi:10.1099/vir.0.82808-0.
   PubMed Web of Science ®Google Scholar
• Abraham J, Corbett KD, Farzan M, et al. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat Struct Mol Biol. 2010 Apr;17(4):438–444. doi:10.1038/nsmb.1772.
   PubMed Web of Science ®Google Scholar
• Helguera G, Jemielity S, Abraham J, et al. An antibody recognizing the apical domain of human transferrin receptor 1 efficiently inhibits the entry of all new world hemorrhagic Fever arenaviruses. J Virol. 2012 Apr;86(7):4024–4028. doi:10.1128/JVI.06397-11.
   PubMed Web of Science ®Google Scholar
• Lee AM, Rojek JM, Spiropoulou CF, et al. Unique small molecule entry inhibitors of hemorrhagic fever arenaviruses. J Biol Chem. 2008 Jul 4;283(27):18734–18742. doi:10.1074/jbc.M802089200.
   PubMed Web of Science ®Google Scholar
• Bolken TC, Laquerre S, Zhang Y, et al. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Res. 2006 Feb;69(2):86–97. doi:10.1016/j.antiviral.2005.10.008.
   PubMed Web of Science ®Google Scholar
• Larson RA, Dai D, Hosack VT, et al. Identification of a broad-spectrum arenavirus entry inhibitor. J Virol. 2008 Nov;82(21):10768–10775. doi:10.1128/JVI.00941-08.
   PubMed Web of Science ®Google Scholar
• Cashman KA, Smith MA, Twenhafel NA, et al. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Res. 2011 Apr;90(1):70–79. doi:10.1016/j.antiviral.2011.02.012.
   PubMed Web of Science ®Google Scholar
• Saeed MF, Kolokoltsov AA, Davey RA. Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. J Virol Methods. 2006 Aug;135(2):143–150. doi:10.1016/j.jviromet.2006.02.011.
   PubMed Web of Science ®Google Scholar
• Madrid PB, Chopra S, Manger ID, et al. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One. 2013;8(4):e60579. doi:10.1371/journal.pone.0060579.
   PubMed Web of Science ®Google Scholar
• Reignier T, Oldenburg J, Noble B, et al. Receptor use by pathogenic arenaviruses. Virology. 2006 Sep 15;353(1):111–120.
   PubMed Web of Science ®Google Scholar
• Lavanya M, Cuevas CD, Thomas M, et al. siRNA screen for genes that affect Junin virus entry uncovers voltage-gated calcium channels as a therapeutic target. Sci Transl Med. 2013 Sep 25;5(204):204ra131. doi:10.1126/scitranslmed.3006827.
   PubMed Web of Science ®Google Scholar
• Koellhoffer JF, Dai Z, Malashkevich VN, et al. Structural characterization of the glycoprotein GP2 core domain from the CAS virus, a novel arenavirus-like species. J Mol Biol. 2014 Apr 3;426(7):1452–1468.
   PubMed Web of Science ®Google Scholar
• Ortiz-Riano E, Cheng BY, de la Torre JC, et al. The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response. J Virol. 2011 Dec;85(24):13038–13048. doi:10.1128/JVI.05834-11.
   PubMed Web of Science ®Google Scholar
• Baird NL, York J, Nunberg JH. Arenavirus infection induces discrete cytosolic structures for RNA replication. J Virol. 2012 Oct;86(20):11301–11310. doi:10.1128/JVI.01635-12.
   PubMed Web of Science ®Google Scholar
• Hastie KM, Liu T, Li S, et al. Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19365–19370. doi:10.1073/pnas.1108515108.
   PubMed Web of Science ®Google Scholar
• Pythoud C, Rodrigo WW, Pasqual G, et al. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J Virol. 2012 Aug;86(15):7728–7738. doi:10.1128/JVI.00187-12.
   PubMed Web of Science ®Google Scholar
• Hastie KM, Kimberlin CR, Zandonatti MA, et al. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3ʹ to 5ʹ exonuclease activity essential for immune suppression. Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2396–2401.
   PubMed Web of Science ®Google Scholar
• Moreno H, Gallego I, Sevilla N, et al. Ribavirin can be mutagenic for arenaviruses. J Virol. 2011 Jul;85(14):7246–7255. doi:10.1128/JVI.00614-11.
   PubMed Web of Science ®Google Scholar
• Neuman BW, Bederka LH, Stein DA, et al. Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors. Antimicrob Agents Chemother. 2011 Oct;55(10):4631–4638. doi:10.1128/AAC.00650-11.
   PubMed Web of Science ®Google Scholar
• Mendenhall M, Russell A, Juelich T, et al. T-705 (favipiravir) inhibition of arenavirus replication in cell culture. Antimicrob Agents Chemother. 2011 Feb;55(2):782–787. doi:10.1128/AAC.01219-10.
   PubMed Web of Science ®Google Scholar
• Gowen BB, Sefing EJ, Westover JB, et al. Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever. Antiviral Res. 2015 Sep;121:132–137.
   PubMed Web of Science ®Google Scholar
• Ortiz-Riano E, Ngo N, Devito S, et al. Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor. J Virol. 2014 Jan;88(2):878–889. doi:10.1128/JVI.02275-13.
   PubMed Web of Science ®Google Scholar
• McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986;314(1):20–26. doi:10.1056/NEJM198601023140104.
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Peters CJ, Mills JN, et al. Prospects for the control of Bolivian hemorrhagic fever. Emerg Infect Dis. 1995 Jul-Sep;1(3):97–100. doi:10.3201/eid0103.950308.
   PubMed Web of Science ®Google Scholar
• Furuta Y, Takahashi K, Shiraki K, et al. T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 2009 Jun;82(3):95–102. doi:10.1016/j.antiviral.2009.02.198.
   PubMed Web of Science ®Google Scholar
• Furuta Y, Gowen BB, Takahashi K, et al. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res. 2013 Nov;100(2):446–454. doi:10.1016/j.antiviral.2013.09.015.
   PubMed Web of Science ®Google Scholar
• Gowen BB, Juelich TL, Sefing EJ, et al. Favipiravir (T-705) inhibits Junin virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever. PLoS Negl Trop Dis. 2013;7(12):e2614. doi:10.1371/journal.pntd.0002614.
   Google Scholar
• Safronetz D, Rosenke K, Westover JB, et al. The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset. Sci Rep. 2015;5:14775. doi:10.1038/srep14775.
   PubMed Web of Science ®Google Scholar
• Oestereich L, Rieger T, Ludtke A, et al. Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model for Lassa fever. J Infect Dis. 2015 Nov 3;213(15 March):935–938.
   PubMedGoogle Scholar
• Andrei G, De Clercq E. Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral Res. 1993 Sep;22(1):45–75.
   PubMed Web of Science ®Google Scholar
• Andrei G, De Clercq E. Inhibitory effect of selected antiviral compounds on arenavirus replication in vitro. Antiviral Res. 1990 Oct-Nov;14(45):287–299.
   PubMed Web of Science ®Google Scholar
• Candurra NA, Maskin L, Damonte EB. Inhibition of arenavirus multiplication in vitro by phenotiazines. Antiviral Res. 1996 Jul;31(3):149–158. doi:10.1016/0166-3542(96)06956-2.
   PubMed Web of Science ®Google Scholar
• Wachsman MB, Lopez EM, Ramirez JA, et al. Antiviral effect of brassinosteroids against herpes virus and arenaviruses. Antivir Chem Chemother. 2000 Jan;11(1):71–77.
   PubMed Web of Science ®Google Scholar
• Emonet SE, Urata S, de la Torre JC. Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology. 2011 Mar 15;411(2):416–425.
   PubMed Web of Science ®Google Scholar
• Lee KJ, Novella IS, Teng MN, et al. NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol. 2000;74(8):3470–3477.
   PubMed Web of Science ®Google Scholar
• Hass M, Golnitz U, Muller S, et al. Replicon system for Lassa virus. J Virol. 2004 Dec;78(24):13793–13803. doi:10.1128/JVI.78.24.13793-13803.2004.
   PubMed Web of Science ®Google Scholar
• Albarino CG, Bergeron E, Erickson BR, et al. Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing. J Virol. 2009 Jun;83(11):5606–5614. doi:10.1128/JVI.00276-09.
   PubMed Web of Science ®Google Scholar
• Droniou-Bonzom ME, Reignier T, Oldenburg JE, et al. Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP. J Virol. 2011 Dec;85(24):13457–13462. doi:10.1128/JVI.05616-11.
   PubMed Web of Science ®Google Scholar
• Rathbun JY, Droniou ME, Damoiseaux R, et al. Novel arenavirus entry inhibitors discovered by using a minigenome rescue system for high-throughput drug screening. J Virol. 2015 Aug;89(16):8428–8443. doi:10.1128/JVI.00997-15.
   PubMed Web of Science ®Google Scholar
• Sanchez AB, de la Torre JC. Rescue of the prototypic arenavirus LCMV entirely from plasmid. Virology. 2006 Jul 5;350(2):370–380. doi:10.1016/j.virol.2006.01.012.
   PubMed Web of Science ®Google Scholar
• Flatz L, Bergthaler A, de la Torre JC, et al. Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4663–4668.
   PubMed Web of Science ®Google Scholar
• Carnec X, Baize S, Reynard S, et al. Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophages. J Virol. 2011 Nov;85(22):12093–12097. doi:10.1128/JVI.00429-11.
   PubMed Web of Science ®Google Scholar
• Grande-Perez A, Martin V, Moreno H, et al. Arenavirus quasispecies and their biological implications. Curr Top Microbiol Immunol. 2015 Oct 16;Part of the series Current Topics in Microbiology and Immunology: 1–45.
   PubMedGoogle Scholar
• Emonet SF, Garidou L, McGavern DB, et al. Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3473–3478. doi:10.1073/pnas.0900088106.
   PubMed Web of Science ®Google Scholar
• Ngo N, Cubitt B, Iwasaki M, et al. Identification and mechanism of action of a novel small-molecule inhibitor of arenavirus multiplication. J Virol. 2015 Nov 1;89(21):10924–10933.
   PubMed Web of Science ®Google Scholar
• Burri DJ, Pasqual G, Rochat C, et al. Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease. J Virol. 2012 May;86(9):4935–4946. doi:10.1128/JVI.00024-12. SKI-1/S1P variants
   PubMed Web of Science ®Google Scholar
• Rojek JM, Pasqual G, Sanchez AB, et al. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses. J Virol. 2010 Jan;84(1):573–584. doi:10.1128/JVI.01697-09.
   PubMed Web of Science ®Google Scholar
• Maisa A, Stroher U, Klenk HD, et al. Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants. PLoS Negl Trop Dis. 2009;3(6):e446. doi:10.1371/journal.pntd.0000446.
   Google Scholar
• Hay BA, Abrams B, Zumbrunn AY, et al. Aminopyrrolidineamide inhibitors of site-1 protease. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4411–4414.
   PubMed Web of Science ®Google Scholar
• Hawkins JL, Robbins MD, Warren LC, et al. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J Pharmacol Exp Ther. 2008 Sep;326(3):801–808. doi:10.1124/jpet.108.139626.
   PubMed Web of Science ®Google Scholar
• Pasquato A, Rochat C, Burri DJ, et al. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242. Virology. 2012 Feb 5;423(1):14–22.
   PubMed Web of Science ®Google Scholar
• Urata S, Yun N, Pasquato A, et al. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J Virol. 2011 Jan;85(2):795–803. doi:10.1128/JVI.02019-10.
   PubMed Web of Science ®Google Scholar
• Stenglein MD, Sanders C, Kistler AL, et al. Identification, characterization, and in vitro culture of highly divergent arenaviruses from boa constrictors and annulated tree boas: candidate etiological agents for snake inclusion body disease. mBio. 2012;3(4):e00180e00112. doi:10.1128/mBio.00180-12.
   Web of Science ®Google Scholar
• Oppliger J, da Palma JR, Burri DJ, et al. A molecular sensor to characterize arenavirus envelope glycoprotein cleavage by subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P). J Virol. 2015 Oct 28;90(2):705–714.
   PubMed Web of Science ®Google Scholar
• Schlie K, Strecker T, Garten W. Maturation cleavage within the ectodomain of Lassa virus glycoprotein relies on stabilization by the cytoplasmic tail. FEBS Lett. 2010 Nov 5;584(21):4379–4382.
   PubMed Web of Science ®Google Scholar
• da Palma JR, Burri DJ, Oppliger J, et al. Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease. J Biol Chem. 2014 Dec 26;289(52):35743–35756.
   PubMed Web of Science ®Google Scholar
• Chen BJ, Lamb RA. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology. 2008 Mar 15;372(2):221–232.
   PubMed Web of Science ®Google Scholar
• Urata S, Yasuda J. Molecular mechanism of arenavirus assembly and budding. Viruses. 2012 Oct;4(10):2049–2079. doi:10.3390/v4102049.
   PubMed Web of Science ®Google Scholar
• Fehling SK, Noda T, Maisner A, et al. The microtubule motor protein KIF13A is involved in intracellular trafficking of the Lassa virus matrix protein Z. Cell Microbiol. 2013 Feb;15(2):315–334. doi:10.1111/cmi.12095.
   PubMed Web of Science ®Google Scholar
• Han Z, Madara JJ, Herbert A, et al. Calcium regulation of hemorrhagic fever virus budding: mechanistic implications for host-oriented therapeutic intervention. PLoS Pathog. 2015 Oct;11(10):e1005220. doi:10.1371/journal.ppat.1005220.
   Google Scholar
• Capul AA, de la Torre JC. A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding. Virology. 2008 Dec 5;382(1):107–114. doi:10.1016/j.virol.2008.09.008.
   PubMed Web of Science ®Google Scholar
• Perez M, Greenwald DL, de la Torre JC. Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol. 2004 Oct;78(20):11443–11448. doi:10.1128/JVI.78.20.11443-11448.2004.
   PubMed Web of Science ®Google Scholar
• Strecker T, Maisa A, Daffis S, et al. The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J. 2006;3:93. doi:10.1186/1743-422X-3-99. subcellular missorting and impairment of virus budding.
   PubMed Web of Science ®Google Scholar
• Pornillos O, Alam SL, Rich RL, et al. Structure and functional interactions of the Tsg101 UEV domain. Embo J. 2002 May 15;21(10):2397–2406.
   PubMed Web of Science ®Google Scholar
• Lu J, Han Z, Liu Y, et al. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol. 2014 May;88(9):4736–4743. doi:10.1128/JVI.03757-13.
   PubMed Web of Science ®Google Scholar
• Vazquez-Calvo A, Martin-Acebes MA, Saiz JC, et al. Inhibition of multiplication of the prototypic arenavirus LCMV by valproic acid. Antiviral Res. 2013 Aug;99(2):172–179. doi:10.1016/j.antiviral.2013.05.012.
   PubMed Web of Science ®Google Scholar
• Urata S, Ngo N, de la Torre JC. The PI3K/Akt pathway contributes to arenavirus budding. J Virol. 2012 Apr;86(8):4578–4585. doi:10.1128/JVI.06604-11.
   PubMed Web of Science ®Google Scholar
• Bisordi I, Levis S, Maeda AY, et al. Pinhal virus, a new arenavirus isolated from Calomys tener in Brazil. Vector Borne Zoonotic Dis. 2015 Oct 26. doi:10.1089/vbz.2014.1708.
   PubMed Web of Science ®Google Scholar